Abstract Details

Title Natalizumab, First Therapy to Demonstrate a Significant Impact on Multiple Sclerosis Disease Severity

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 180

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Francois H. Jacques, MD (Clinique Neuro-Outaouais) PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����